Insider Transactions in Q2 2023 at A Ikido Pharma Inc. (AIKI)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Soo Yu Director |
BUY
Grant, award, or other acquisition
|
Direct |
529,715
+39.23%
|
$1,059,430
$2.58 P/Share
|
|
Jun 14
2023
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
1,319
+0.61%
|
$2,638
$2.87 P/Share
|
|
Jun 13
2023
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
506
+0.24%
|
$1,012
$2.89 P/Share
|
|
Jun 09
2023
|
Kyle Michael Wool President |
BUY
Open market or private purchase
|
Direct |
1,500
+0.53%
|
$3,000
$2.76 P/Share
|
|
Jun 08
2023
|
Kyle Michael Wool President |
BUY
Open market or private purchase
|
Direct |
424
+0.15%
|
$848
$2.59 P/Share
|
|
May 30
2023
|
Kyle Michael Wool President |
BUY
Open market or private purchase
|
Direct |
2,000
+0.71%
|
$4,000
$2.59 P/Share
|
|
May 24
2023
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.93%
|
$4,000
$2.75 P/Share
|
|
May 18
2023
|
Christopher Franklin Devall COO |
BUY
Open market or private purchase
|
Direct |
1,500
+6.66%
|
$3,000
$2.94 P/Share
|
|
May 18
2023
|
Kyle Michael Wool President |
BUY
Open market or private purchase
|
Direct |
2,058
+0.37%
|
$4,116
$2.74 P/Share
|
|
May 17
2023
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.94%
|
$4,000
$2.77 P/Share
|
|
May 17
2023
|
Kyle Michael Wool President |
BUY
Open market or private purchase
|
Direct |
2,000
+0.72%
|
$4,000
$2.77 P/Share
|
|
May 16
2023
|
Kyle Michael Wool President |
BUY
Open market or private purchase
|
Direct |
2,000
+0.72%
|
$4,000
$2.71 P/Share
|
|
May 16
2023
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.95%
|
$4,000
$2.77 P/Share
|
|
Apr 05
2023
|
Christopher Franklin Devall COO |
BUY
Open market or private purchase
|
Direct |
5,698
+22.58%
|
$17,094
$3.51 P/Share
|
|
Apr 04
2023
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
30,000
+12.68%
|
$90,000
$3.44 P/Share
|